Clinical Trials List
Protocol NumberAP24534-14-203
Completed
2015-10-01 - 2024-12-31
Phase II
Recruiting1
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Jih-Luh Tang Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- 陳尹愷 Division of Hematology & Oncology
- CHANG-HAO YANG Division of Ophthalmology
- 劉家豪 Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
276 participants
